New hope to stop deadly clots in High-Risk surgeries

NCT ID NCT04918173

Recruiting now Disease control Sponsor: Octapharma Source: ClinicalTrials.gov ↗

Summary

This study is testing a medication called Atenativ to see if it can safely prevent dangerous blood clots in people with a rare inherited condition that makes them prone to clotting. It focuses on adults who need high-risk surgery or are about to give birth, as these events greatly increase their clot risk. The main goal is to see how many clots occur while patients are protected by this treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aversi Clinic
RECRUITING

Tbilisi, Georgia
Bleeding and Clotting Disorders Institute
RECRUITING

Peoria, Illinois, 61615, United States
Central University Hospital of Asturias
RECRUITING

Oviedo, Principality of Asturias, 33011, Spain
Centre Hospitalier Universitaire de Rouen (CHU de Rouen) - Centre de Traitement des Maladies Hemorragiques (CRTH) (Centre d'Hemophiles)
RECRUITING

Rouen, France
Centre de Référence de l'Hémophilie Unité d'Hémostase Clinique Hôpital Cardiologique Louis Pradel
RECRUITING

Bron, France
Centre for Thrombosis and Haemaostasis
RECRUITING

Nymburk, Czechia
Clinical Center of Serbia
RECRUITING

Belgrade, Serbia
Duke University
RECRUITING

Durham, North Carolina, 27708, United States
Emergency County Hospital Craiova
RECRUITING

Craiova, Romania
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING

Roma, Italy
Georgetown University
RECRUITING

Washington D.C., District of Columbia, 20057, United States
Gerinnungszentrum Rhein-Ruhr
RECRUITING

Duisburg, Germany
Hospital Universitario La Paz
RECRUITING

Madrid, 28046, Spain
Hospital Universitario Morales Meseguer
RECRUITING

Murcia, Spain
Klinik fur Angiologie Hamostaseologie Haus 12 A Gerinnungssprechstunde
RECRUITING

Berlin, Germany
Ourense University Hospital
RECRUITING

Ourense, 32005, Spain
Rabin Medical Centre, Institute of Haematology
RECRUITING

Petah Tikva, Israel
Royal-free Hospital-Katherine Dormandy Haemophilia and Thrombosis Centre
RECRUITING

London, United Kingdom
Sheba Medical Centre
RECRUITING

Ramat Gan, Israel
St. Thomas Hospital
RECRUITING

London, United Kingdom
UKB Bonn Institut für Experimentelle Hämatologie und Transfusionsmedizin
RECRUITING

Bonn, Germany
Unita Strutturale Complessa di Immunoematologia e Medicina Trasfusionale -Dipartimento Interaziendale di Medicina Trasfusionale ed Ematologia - ASST Papa Giovanni XXIII ematologia Piazza OMS, 1
RECRUITING

Bergamo, 24127, Italy
Universita degli Studi di Milano - IRCCS Ospedale Maggiore Policlinico - Centro Emofilia e Trombosi Angelo Bianchi Bonomi
RECRUITING

Milan, Italy
University Hospital of Reims
RECRUITING

Reims, France
University of Debrecen, Medical and Health Science Centre
RECRUITING

Debrecen, Hungary
University of Miami
RECRUITING

Miami, Florida, 33124, United States
University of Padua Medical School
RECRUITING

Padua, Italy
Universitätsklinik für Innere Medizin Klinische Abteilung für Hämatologie und Hämostaseologie
RECRUITING

Vienna, Austria
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States
Yeolyan Hematology and Oncology Centre
NOT_YET_RECRUITING

Yerevan, Armenia

Conditions

Explore the condition pages connected to this study.

CONGENITAL ANTITHROMBIN DEFICIENCY